NORTHBROOK, Ill., Feb. 11, 2016 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted and flexible molecular diagnostics, announced today that it will report its results for the fourth quarter ended December 30, 2015 after the market close on Wednesday, February 24, 2016.  The company will also hold a live investor conference call and webcast at 5pm Eastern Time.

Conference Call & Webcast
Wednesday, February 24 @ 5pm Eastern Time

About Nanosphere, Inc.

Nanosphere is enhancing medicine through targeted molecular diagnostics that result in earlier disease detection, optimal patient treatment and improved healthcare economics. The Company’s versatile technology platform, the Verigene® System, enables clinicians to rapidly detect the most complex, costly and deadly infectious diseases through a low cost and simple-to-use multiplexed diagnostic test. The combination of this innovative technology and Nanosphere’s customer-driven solutions keeps commitment to the patient at the forefront of its business. Nanosphere is based in Northbrook, IL. Additional information is available at http://www.nanosphere.us.

Contacts
Investors:
Michael Rice, LifeSci Advisors
646-597-6979
mrice@lifesciadvisors.com 
Media:
Zachary Crowther, Director of Marketing
847-400-9074
zcrowther@nanosphere.us